Answers are grounded in this paper and cite their sources.
Ongoing research uncovers genetic susceptibility in rheumatic heart disease, suggesting implications for vaccines and therapies.
I will cover updates on the latest insights into host genetic susceptibility to rheumatic heart disease including highlights from ongoing unpublished work in my laboratory. This will include a description of how complement and immunoglobulin genes appear to be the key players and how genetic variation in these complex regions is likely to impact immune responses to the causative streptococci. Finally, I will summarise the implications of these insights for development of vaccines and novel therapeutics.
No takes yet. Share an insight, caveat, or question.
Tom Parks (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: